'Metabolically healthy obesity': origins and implications.

When humans eat more and exercise less, they tend to become obese and unhealthy. The molecular pathways that link obesity to serious diseases like Type 2 diabetes and cardiovascular disease have become a subject of intensive scientific investigation because the exploding prevalence of obesity worldwide represents a grave new threat to the health of hundreds of millions of people. However, obesity is not always destiny. Two important clinical populations have been valuable to understand the mechanisms behind this conundrum: individuals who exhibit metabolic dysfunction, diabetes and elevated cardiovascular disease risk despite a lean body type, and individuals who are relatively protected from these dangers despite significant obesity. Study of this second group of 'metabolically healthy obese' people in particular has been revealing because such individuals exhibit specific, identifiable, anatomic, cellular and molecular features that set them apart from the rest of us who suffer declining health with increasing weight. Here, we examine some of these features, including some mouse models that are informative of mechanism, and suggest hypotheses for further study, including the possibility that genes and pathways of the immune system might offer new diagnostic or therapeutic targets.

[1]  A. Belkina,et al.  BET domain co-regulators in obesity, inflammation and cancer , 2012, Nature Reviews Cancer.

[2]  D. Chisholm,et al.  The metabolically obese, normal-weight individual revisited. , 1998, Diabetes.

[3]  Stephen J. Weiss,et al.  A Pericellular Collagenase Directs the 3-Dimensional Development of White Adipose Tissue , 2006, Cell.

[4]  Richard T. Lee,et al.  Thioredoxin Regulates Adipogenesis through Thioredoxin-interacting Protein (Txnip) Protein Stability*♦ , 2011, The Journal of Biological Chemistry.

[5]  S. Kiechl,et al.  U-Shaped and J-Shaped Relationships Between Serum Insulin and Coronary Heart Disease in the General Population: The Bruneck Study , 1998, Diabetes Care.

[6]  A. Vidal-Puig,et al.  Adipose tissue expandability: the metabolic problems of obesity may arise from the inability to become more obese. , 2008, Biochemical Society transactions.

[7]  Y. Hayashi,et al.  Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.

[8]  F. Liu,et al.  Fat-Specific DsbA-L Overexpression Promotes Adiponectin Multimerization and Protects Mice From Diet-Induced Obesity and Insulin Resistance , 2012, Diabetes.

[9]  C. Bouchard,et al.  Overfeeding in identical twins: 5-year postoverfeeding results. , 1996, Metabolism: clinical and experimental.

[10]  C. Herder,et al.  Relationship between adipocyte size and adipokine expression and secretion. , 2007, The Journal of clinical endocrinology and metabolism.

[11]  Y. Ohnishi,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.

[12]  M. Blüher Are there still healthy obese patients? , 2012, Current opinion in endocrinology, diabetes, and obesity.

[13]  Thomas L. Rothstein,et al.  Eμ-BRD2 transgenic mice develop B-cell lymphoma and leukemia , 2004 .

[14]  P. Puigserver,et al.  Transcriptional regulation of adipogenesis. , 2000, Genes & development.

[15]  D. Faller,et al.  Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. , 2005, The Biochemical journal.

[16]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[17]  Roger A. Davis,et al.  Thioredoxin‐interacting protein deficiency induces Akt/Bcl‐xL signaling and pancreatic beta‐cell mass and protects against diabetes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[19]  L. Lynch,et al.  Preadipocyte factor-1 is associated with metabolic profile in severe obesity. , 2011, The Journal of clinical endocrinology and metabolism.

[20]  J. Knight,et al.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease , 2010, Genes and Immunity.

[21]  B. Spiegelman,et al.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. , 1999, Molecular cell.

[22]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[23]  J. Deeney,et al.  Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes. , 2013, Vitamins and hormones.

[24]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[25]  K. Strissel,et al.  Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice , 2010, Diabetes.

[26]  T. Funahashi,et al.  Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.

[27]  Jean-Daniel Zucker,et al.  Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass Loss , 2010, Diabetes.

[28]  C. Duman,et al.  Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. , 2004, The Journal of clinical endocrinology and metabolism.

[29]  K. Pennert,et al.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. , 1984, British medical journal.

[30]  H. Masutani,et al.  Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity , 2010, Nature communications.

[31]  T. Miyazaki,et al.  AIMing at Metabolic Syndrome , 2011 .

[32]  A Tremblay,et al.  The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.

[33]  T. Iwanaga,et al.  Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via inhibition of fatty acid synthase activity. , 2010, Cell metabolism.

[34]  M. Blüher The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals , 2010, Current opinion in lipidology.

[35]  Richard N Bergman,et al.  Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome , 2006, Obesity.

[36]  K. Clément,et al.  Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity , 2008, Genome Biology.

[37]  D. Cibula,et al.  Insulin sensitivity in women with polycystic ovary syndrome. , 2004, The Journal of clinical endocrinology and metabolism.

[38]  B. Zinman,et al.  Obesity Is a Major Determinant of the Association of C-Reactive Protein Levels and the Metabolic Syndrome in Type 2 Diabetes , 2006, Diabetes.

[39]  M. Birnbaum,et al.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.

[40]  Julia K Mader,et al.  Adipose tissue, inflammation and cardiovascular disease. , 2010, Revista da Associacao Medica Brasileira.

[41]  D. DuBois,et al.  Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats , 2011, PloS one.

[42]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[43]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[44]  Y. Matsuzawa Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[45]  Y. Deshaies,et al.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. , 2004, Endocrinology.

[46]  T. Miyazaki,et al.  AIMing at metabolic syndrome. -Towards the development of novel therapies for metabolic diseases via apoptosis inhibitor of macrophage (AIM).-. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[47]  Bohan Wang,et al.  Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? , 2008, British Journal of Nutrition.

[48]  E. A. Sims,et al.  Are there persons who are obese, but metabolically healthy? , 2001, Metabolism: clinical and experimental.

[49]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[50]  J. Colwell Multifactorial aspects of the treatment of the type II diabetic patient. , 1997, Metabolism: clinical and experimental.

[51]  A Tremblay,et al.  Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.

[52]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[53]  Ricardo Azziz,et al.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis , 2011, Nature Reviews Endocrinology.

[54]  R. Abbott,et al.  CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN , 1987, The Lancet.

[55]  C. Peterson,et al.  Adipose tissue macrophages in insulin resistant subjects are 1 associated with collagen VI, fibrosis and demonstrate 2 alternative activation , 2010 .

[56]  F. Wong-Staal,et al.  Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. , 2007, The Journal of endocrinology.

[57]  H. Oflaz,et al.  Determination of endothelial function and early atherosclerotic changes in healthy obese women. , 2003, Diabetes, nutrition & metabolism.

[58]  G. Sesti,et al.  Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals , 2008, Obesity.

[59]  Xu Yan,et al.  Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation. , 2010, American journal of physiology. Endocrinology and metabolism.

[60]  Nader Rifai,et al.  Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.

[61]  D. Bowen,et al.  Uncoupling Obesity from Cancer: Bromodomain Co-regulators That Control Inflammatory Networks , 2013 .

[62]  Hakon Hakonarson,et al.  Genome-wide association studies in type 1 diabetes , 2009, Current diabetes reports.

[63]  Wei Zhang,et al.  The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis , 2009, BMC public health.

[64]  G. Denis,et al.  The outliers become a stampede as immunometabolism reaches a tipping point , 2012, Immunological reviews.

[65]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[66]  A. Garg Adipose tissue dysfunction in obesity and lipodystrophy. , 2006, Clinical cornerstone.

[67]  L. Luzi,et al.  Prevalence, Metabolic Features, and Prognosis of Metabolically Healthy Obese Italian Individuals , 2010, Diabetes Care.

[68]  G. Reaven,et al.  Insulin Resistance and Hyperinsulinemia , 2008, Diabetes Care.

[69]  A. Işık,et al.  Serum adiponectin and vaspin levels in rheumatoid arthritis. , 2010, Archives of medical research.

[70]  Pardis C Sabeti,et al.  A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC , 2006, Nature Genetics.

[71]  D. Goulis,et al.  Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. , 2009, Human reproduction update.

[72]  Kayoung Lee Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. , 2009, Asia Pacific journal of clinical nutrition.

[73]  Ralph B D'Agostino,et al.  Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. , 2006, The Journal of clinical endocrinology and metabolism.

[74]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[75]  C. Aguilar-Salinas,et al.  High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.

[76]  J. Vague Sexual differentiation; Factor determining forms of obesity. , 1947 .

[77]  Jacqueline Capeau,et al.  Recent advances in the relationship between obesity, inflammation, and insulin resistance. , 2006, European cytokine network.

[78]  V. Hombach,et al.  T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[79]  Mahboob Rahman,et al.  Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: Risk reduction in a chronic inflammatory disease , 2011, Arthritis care & research.

[80]  N. LeBrasseur,et al.  Brd2 disruption in mice causes severe obesity without Type 2 diabetes. , 2009, The Biochemical journal.

[81]  C. Bouchard,et al.  Genetic aspects of susceptibility to obesity and related dyslipidemias , 1992, Molecular and Cellular Biochemistry.

[82]  G. Shulman,et al.  Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance , 2011, Diabetes.

[83]  R. Ross,et al.  Effects of Weight Loss Among Metabolically Healthy Obese Men and Women , 2010, Diabetes Care.

[84]  C. Bouchard,et al.  Role of Deep Abdominal Fat in the Association Between Regional Adipose Tissue Distribution and Glucose Tolerance in Obese Women , 1989, Diabetes.

[85]  Richard T. Lee,et al.  Deletion of the α-Arrestin Protein Txnip in Mice Promotes Adiposity and Adipogenesis While Preserving Insulin Sensitivity , 2010, Diabetes.

[86]  C. Duman,et al.  Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. , 2005, The Journal of clinical endocrinology and metabolism.

[87]  O. Ohara,et al.  Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue , 2011, Proceedings of the National Academy of Sciences.

[88]  M. Quinn,et al.  Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. , 2011, Rheumatology.

[89]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[90]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[91]  C. Bogardus,et al.  A Genome‐Wide Association Study of BMI in American Indians , 2011, Obesity.

[92]  N. Ruderman,et al.  The "metabolically-obese," normal-weight individual. , 1981, The American journal of clinical nutrition.

[93]  Remi Rabasa-Lhoret,et al.  The metabolically healthy but obese individual presents a favorable inflammation profile. , 2005, The Journal of clinical endocrinology and metabolism.

[94]  G. Shulman,et al.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue. , 2007, The Journal of clinical investigation.

[95]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[96]  Y. Matsuzawa,et al.  Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. , 1997, Diabetes/metabolism reviews.

[97]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[98]  B. Spiegelman,et al.  PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro , 1999 .

[99]  N. Ruderman,et al.  Obesity-associated disorders in normal-weight individuals: some speculations. , 1982, International journal of obesity.

[100]  E. Ravussin,et al.  Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 Diabetes , 2006, Obesity.

[101]  Eric Ravussin,et al.  Adipose tissue collagen VI in obesity. , 2009, The Journal of clinical endocrinology and metabolism.

[102]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[103]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[104]  Y. Matsuzawa,et al.  Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.

[105]  A. Eliopoulos,et al.  Tpl2 kinase signal transduction in inflammation and cancer. , 2011, Cancer letters.

[106]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[107]  A. Belkina,et al.  Obesity genes and insulin resistance. , 2010, Current opinion in endocrinology, diabetes, and obesity.

[108]  D. Fuchs,et al.  Inflammation, adiponectin, obesity and cardiovascular risk. , 2010, Current medicinal chemistry.

[109]  Philipp E. Scherer,et al.  Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI , 2008, Molecular and Cellular Biology.

[110]  G. Denis Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation. , 2010, Discovery medicine.

[111]  B. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.

[112]  Lars Alfredsson,et al.  Specific interaction between genotype, smoking and autoimmunity to citrullinated α-enolase in the etiology of rheumatoid arthritis , 2009, Nature Genetics.

[113]  A. Attie,et al.  Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue , 2009, Molecular and Cellular Biology.

[114]  A. Butte,et al.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[115]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.

[116]  D. Lauderdale,et al.  Trends in bariatric surgical procedures. , 2005, JAMA.

[117]  K. Walsh,et al.  Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.

[118]  R. Cardiff,et al.  - BRD 2 transgenic mice develop B-cell lymphoma and leukemia , 2004 .

[119]  G. Denis,et al.  An emerging role for bromodomain‐containing proteins in chromatin regulation and transcriptional control of adipogenesis , 2010, FEBS letters.

[120]  J. Després,et al.  Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. , 2005, The Journal of clinical endocrinology and metabolism.

[121]  R. Yu,et al.  Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters , 2006, International Journal of Obesity.